Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance

2014 ◽  
Vol 50 (2) ◽  
pp. 379-387 ◽  
Author(s):  
Shuang Wang ◽  
Shisheng Li ◽  
Xinming Yang ◽  
Shu Yang ◽  
Shuhua Liu ◽  
...  

2012 ◽  
Vol 29 (5) ◽  
pp. 3381-3388 ◽  
Author(s):  
Zhengzheng Liu ◽  
Xin Zhang ◽  
Donghai Huang ◽  
Yong Liu ◽  
Xiaozhe Zhang ◽  
...  


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Shuiting Zhang ◽  
Chao Liu ◽  
Guo Li ◽  
Yong Liu ◽  
Xingwei Wang ◽  
...  


2021 ◽  
Author(s):  
Shuiting Zhang ◽  
Yuanzheng Qiu

Abstract Background: Squamous cell carcinoma of the head and neck (SCCHN) is one of the most common types of cancer and is a relevant cause of cancer-related deaths. Our previous study has revealed that makorin ring finger protein 3 (MKRN3) may serve as a key regulator of the SCCHN tumorigenesis, but its specific role in SCCHN progression has never been reported.Method: TCGA data analysis and qPCR were used to quantify the level of MKRN3 in SCCHN and its clinical significance was further analyzed. Immunohistochemical staining or immunoblotting analysis was carried out to detect protein expression.Results: MKRN3 was ectopically expressed between cancerous and noncancerous SCCHN tissues, and its expression level was tightly associated with high T classifications and advanced clinical stages. qPCR analysis revealed that MKRN3 was upregulated in the SCCHN cell line. Moreover, Kaplan–Meier and Cox regression analyses indicated that SCCHN patients with high MKRN3 expression had poorer prognosis and that MKRN3 was a potential prognostic factor for SCCHN. Using gene ontology and Kyoto Encyclopedia of Genes and Genomes analyses, we determined that MKRN3 may be involved in the regulation of synthesis and metabolism, cell growth, death and motility, and cancer pathways associated with SCCHN progression. Mechanism investigation further revealed that P53, as a potential target of MKRN3, may implicate in the SCCHN tumorigenesis mediated by MKRN3.Conclusions: MKRN3 is a valuable predictive biomarker and potential therapeutic target in SCCHN.



2010 ◽  
Vol 46 (16) ◽  
pp. 3007-3015 ◽  
Author(s):  
Yong Liu ◽  
Congliang Xie ◽  
Xin Zhang ◽  
Donghai Huang ◽  
Xiaojuan Zhou ◽  
...  


Head & Neck ◽  
2013 ◽  
Vol 36 (3) ◽  
pp. 385-392 ◽  
Author(s):  
Sarah Elizabeth Wheeler ◽  
Huifang Shi ◽  
Fangchen Lin ◽  
Sumana Dasari ◽  
Joseph Bednash ◽  
...  




2020 ◽  
Vol 37 (2) ◽  
pp. 283-292 ◽  
Author(s):  
Jipei Liao ◽  
Zejia Yang ◽  
Brandon Carter-Cooper ◽  
Elizabeth T. Chang ◽  
Eun Yong Choi ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document